These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 200389)

  • 1. Cerebrotendinous cholestanolosis in relation to other cerebral xanthomatoses.
    de Jong JG; van Gent CM; Delleman JW
    Clin Neurol Neurosurg; 1977; 79(4):253-72. PubMed ID: 200389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrotendinous xanthomatosis: a defect in cellular sterol biosynthetic control.
    Barron JL; Maxwell JU; Rutherfoord GS
    J Inherit Metab Dis; 1982; 5(2):91-3. PubMed ID: 6820431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism.
    Salen G
    Ann Intern Med; 1971 Dec; 75(6):843-51. PubMed ID: 5134895
    [No Abstract]   [Full Text] [Related]  

  • 4. Type IIa hyperlipoproteinemia masquerading as cerebrotendinous xanthomatosis.
    Ijichi S; Ijichi N; Niina K; Kuriyama M; Izumo S; Nakamura F; Osame M
    J Neurol Sci; 1989 Dec; 94(1-3):101-5. PubMed ID: 2614461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases.
    Canelas HM; Quintão EC; Scaff M; Vasconcelos KS; Brotto MW
    Acta Neurol Scand; 1983 May; 67(5):305-11. PubMed ID: 6410671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrotendinous xanthomatosis in three siblings from a Taiwanese family.
    Chang WN; Kuriyama M; Lui CC; Jeng SF; Chen WJ; Chee EC
    J Formos Med Assoc; 1992 Dec; 91(12):1190-4. PubMed ID: 1363642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrotendinous xanthomatosis (cholestanolosis). Investigations on two sisters and their family.
    Schreiner A; Hopen G; Skrede S
    Acta Neurol Scand; 1975 May; 51(5):405-16. PubMed ID: 1130172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Grundy SM
    J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
    Moghadasian MH; Salen G; Frohlich JJ; Scudamore CH
    Arch Neurol; 2002 Apr; 59(4):527-9. PubMed ID: 11939886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrotendinous xanthomatosis with cholestanolaemia--involvement of five individuals in a Malay family.
    Othman NH; Rahman SA
    Med J Malaysia; 1990 Dec; 45(4):275-80. PubMed ID: 2152046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
    Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O
    J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
    Skrede S; Bjørkhem I
    Scand J Clin Lab Invest Suppl; 1985; 177():15-21. PubMed ID: 3865344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of carriers of cerebrotendinous xanthomatosis.
    Koopman BJ; Waterreus RJ; Van den Brekel HW; Wolthers BG
    Clin Chim Acta; 1986 Jul; 158(2):179-85. PubMed ID: 3742821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
    Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
    J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis.
    Salen G; Polito A
    J Clin Invest; 1972 Jan; 51(1):134-40. PubMed ID: 4550120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens.
    McKenna P; Morgan SJ; Bosanquet RC; Laker MF
    Br J Ophthalmol; 1990 Oct; 74(10):629-30. PubMed ID: 2285688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
    Björkhem I; Buchmann MS; Skrede S
    Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Pedley TA; Emerson RG; Warner CL; Rowland LP; Salen G
    Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric disorders in patients with cerebrotendinous xanthomatosis.
    Berginer VM; Foster NL; Sadowsky M; Townsend JA; Siegel GJ; Salen G
    Am J Psychiatry; 1988 Mar; 145(3):354-7. PubMed ID: 3344851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.